4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001209191-16-132658
CIK 0001382911operating
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 1:23 PM ET
Size
5.8 KB
Accession
0001209191-16-132658
Insider Transaction Report
Form 4
Endicott David J.
Director
Transactions
- Award
Stock Option
2016-07-12+15,000→ 15,000 totalExercise: $4.02Exp: 2026-07-11→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following 07/08/2016, subject to the Director's continuing service on the Board through each such date; provided, that if a Change in Control (as defined in the Plan) occurs, such option, to the extent unvested, shall become fully vested immediately prior to such Change in Control, subject to the Director's continuing service on the Board, as set forth in the applicable stock option grant notice and stock option agreement for such Director.
- [F2]Not Applicable
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 1:23 PM ET
- Size
- 5.8 KB